Terkko Navigator / -/ Feeds / " ( ( Pitkä QT - ( ( Oireyhtymä )|( Syndroma )|( Sdr )|( Oireyhtymät )|( Syndrooma )|( S"

The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome

Cells, Vol. 11, Pages 2495: In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment

Effects of beta-blockers on ventricular repolarization documented by 24-h electrocardiography in long-QT syndrome type 2

Long QT Syndrome

Long QT syndrome and left ventricular non-compaction in a family with KCNH2 mutation: A case report

Cardiogenetics, Vol. 12, Pages 90-101: Genetic Diagnostics Contribute to the Risk Stratification for Major Arrhythmic Events in Pediatric Patients with Long QT Syndrome Type 1–3

Ratio of Late to Early T-Wave Peak Amplitude in 24-h Electrocardiographic Recordings as Indicator of Symptom History in Patients With Long-QT Syndrome Types 1 and 2.

Ratio of late to early T-wave peak amplitude in 24-h electrocardiographic recordings as indicator of symptom history in patients with long-QT Syndrome types 1 and 2.

Cloninger's temperament traits and inherited long QT syndrome.

Work Stress and the Long QT Syndrome: High Job Strain and Effort-Reward Imbalance at Work Associated With Arrhythmic Risk in the Long QT Syndrome.

Stressful life events and depressive symptoms among symptomatic long QT syndrome patients.

Follow-up of 316 Molecularly Defined Pediatric Long QT Syndrome Patients - Clinical Course, Treatments and Side Effects.

Stressful life events and depressive symptoms among symptomatic long QT syndrome patients.

High Prevalence of Late-Appearing T-Wave in Patients With Long QT Syndrome Type 8.

Stressful life events and depressive symptoms among symptomatic long QT syndrome patients

The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23

Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)

Molecular screening of selected long QT syndrome (LQTS) mutations in 165 consecutive bodies found in water.

Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients.

Effects of Beta-Blocker Therapy on Ventricular Repolarization Documented by 24-h Electrocardiography in Patients With Type 1 Long-QT Syndrome.

beta1-Adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome.

beta1-Adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome.

Ventricular Repolarization and Heart Rate Responses During Cardiovascular Autonomic Function Testing in LQT1 Subtype of Long QT Syndrome.

When I go in to wake them ... I wonder: parental perceptions about congenital long QT syndrome.

Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.

Diagnostic Miscues in Congenital Long-QT Syndrome.

Electrocardiographic interventricular dispersion of repolarization during autonomic adaptation in LQT1 subtype of long QT syndrome.

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy.

High prevalence of four long QT syndrome founder mutations in the Finnish population.

High prevalence of four long QT syndrome founder mutations in the Finnish population.

High prevalence of four long QT syndrome founder mutations in the Finnish population.

High prevalence of four long QT syndrome founder mutations in the Finnish population.

High prevalence of four long QT syndrome founder mutations in the Finnish population.

High prevalence of four long QT syndrome founder mutations in the Finnish population.

High prevalence of four long QT syndrome founder mutations in the Finnish population.

High prevalence of four long QT syndrome founder mutations in the Finnish population.

Depressive symptoms in the congenital long QT syndrome.

A history of stressful life events, prolonged mental stress and arrhythmic events in inherited long QT syndrome.

Implantable Cardioverter Defibrillator Therapy for Congenital Long QT Syndrome: A Single Center Experience.

KCNE1 D85N polymorphism - a sex-specific modifier in type 1 long QT syndrome?

Human disease model for long QT syndrome type 2 using iPS cells demonstrates arrhythmogenic characteristics in cell culture.

Human disease model for long QT syndrome type 2 using iPS cells demonstrates arrhythmogenic characteristics in cell culture.

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.

Stress Proneness in Molecularly Defined Long QT Syndrome: A Study Using Temperament Assessment by Behavioural Inhibition System Scale.

Identification of a KCNQ1 Polymorphism Acting as a Protective Modifier against Arrhythmic Risk in Long QT Syndrome.

The Return of Unexpected Research Results in a Biobank Study and Referral to Health Care for Heritable Long QT Syndrome.

The Return of Unexpected Research Results in a Biobank Study and Referral to Health Care for Heritable Long QT Syndrome.

The Return of Unexpected Research Results in a Biobank Study and Referral to Health Care for Heritable Long QT Syndrome.

Follow-up of 316 Molecularly Defined Pediatric Long QT Syndrome Patients - Clinical Course, Treatments and Side Effects.

Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes.